戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ion (55%) against virus challenge in outbred New Zealand White rabbits.
2 eal keratocytes isolated from the corneas of New Zealand White rabbits.
3 ) was performed on the left eyes of 20 adult New Zealand White rabbits.
4 induced by coronary artery ligation in adult New Zealand White rabbits.
5 ne (n = 5) were given in a volume of 2 ml to New Zealand white rabbits.
6 natured Oms66 (hOms66) were used to immunize New Zealand White rabbits.
7 li was deposited onto the abraded corneas of New Zealand White rabbits.
8  a major organ in catabolism of Lp B-70.5 in New Zealand white rabbits.
9 next to each other in both thighs in 10 male New Zealand white rabbits.
10  by using confocal microscopy in vivo in six New Zealand White rabbits.
11            Seventeen anesthetized adult male New Zealand White rabbits.
12      The coronary ligation model was used in New Zealand white rabbits.
13 nted them into carotid arteries of recipient New Zealand White rabbits.
14 tilated, pump-perfused lungs from euthanized New Zealand White rabbits.
15 ed on anaesthetized, artificially ventilated New Zealand White rabbits.
16 ging experimental atherosclerotic lesions in New Zealand White rabbits.
17 ained from the lacrimal glands of adult male New Zealand White rabbits.
18 ies treated with mitomycin-C were created in New Zealand White rabbits.
19 lly into the vitreous of the right eye of 10 New Zealand White rabbits.
20 DL)-mediated endothelial dysfunction in male New Zealand White rabbits.
21 ted into the vitreous of the right eye of 10 New Zealand White rabbits.
22 e tubercle bacilli in commercially available New Zealand white rabbits.
23 loon-damaged, flow-reduced iliac arteries of New Zealand White rabbits.
24 rmal or previously denuded iliac arteries of New Zealand White rabbits.
25 ameter) were performed using microneedles in New Zealand white rabbits.
26 twelve 3-month-old and ten 12-month-old male New Zealand White rabbits.
27 e created at the root of the right CCA in 16 New Zealand white rabbits.
28 hemia and hemorrhage in large clot embolized New Zealand white rabbits.
29 , obtained from both Sprague-Dawley rats and New Zealand White rabbits.
30 superficial femoral artery was induced in 14 New Zealand white rabbits.
31                Experiments were performed on New Zealand White rabbits.
32 -8 weeks) and aged (approximately 30 months) New Zealand White rabbits.
33 A) to detect atherosclerotic lesions in male New Zealand White rabbits.
34 r samples from normal and dry eyes of female New Zealand White rabbits.
35 ently available methods, of measuring IOP in New Zealand White rabbits.
36 es obtained from naive untreated and treated New Zealand White rabbits.
37 asuring IOP in the range of 0 to 50 mm Hg in New Zealand White rabbits.
38 g growth and invasion inhibitory antisera in New Zealand White rabbits.
39  artery angioplasty was performed in 25 male New Zealand White rabbits.
40 tracellularly in retinas isolated from adult New Zealand White rabbits.
41 al division of the medial geniculate body of New Zealand white rabbits.
42      Experiments were carried out on 36 male New Zealand White rabbits, 13 normal and 23 CHF.
43                                              New Zealand White rabbits (2 kg) 12 days after implantat
44                                      Fifteen New Zealand white rabbits (3.2+/-0.39 kg).
45                                           In New Zealand White rabbits, 3 days of treatment with NTG
46 ed by a 0.5% cholesterol diet for 16 wk in 7 New Zealand White rabbits; 5 unmanipulated rabbits, fed
47 noparticles-47 [MION-47]) in cholesterol-fed New Zealand White rabbits 6 months after balloon injury.
48                             Two groups of 12 New Zealand White rabbits ((99m)Tc-MAG3 and (99m)Tc-DTPA
49 endrimer eye drop formulation was studied in New Zealand White rabbits after a single dose or multipl
50  distribution of carboplatin was examined in New Zealand White Rabbits after a single intravenous inf
51            It was implanted into six eyes of New Zealand White rabbits after extracapsular lens extra
52 rnal administration of aluminum maltolate to New Zealand white rabbits, an animal system relevant to
53                                              New Zealand White rabbits and A/J (H-2K) mice produced h
54                   Corneas were obtained from New Zealand White rabbits and cultured ex vivo using sta
55 ed from gluteal biopsies from volunteers and New Zealand White rabbits and mounted on a wire myograph
56 llow microneedle was performed in the eye of New Zealand White rabbits and was found to reduce IOP in
57     In vivo experiments were performed using New Zealand White rabbits at several times points after
58           Atherosclerosis was produced in 34 New Zealand White rabbits by balloon de-endotheliazation
59               Atherosclerosis was induced in New Zealand white rabbits by cholesterol diet and endoth
60                      CHF was induced in male New Zealand White rabbits by chronic ventricular tachyca
61  A single retinal detachment was produced in New Zealand White rabbits by injecting approximately 50
62              Osteomyelitis was induced in 12 New Zealand white rabbits by injecting staphylococcus au
63 wing large clot embolism-induced ischemia in New Zealand white rabbits by intracisternally administer
64            Atherosclerosis was induced in 14 New Zealand White rabbits by means of a 1% cholesterol d
65           Saccular aneurysms were created in New Zealand White rabbits by using vessel ligation with
66  of detrusor myocytes following PBOO in male New Zealand White rabbits compared to that of controls.
67                              Series I: Adult New Zealand White rabbit corneas were mounted in perfusi
68                                        Adult New Zealand White rabbit corneas were treated with 2 mM
69 onocclusive periarterial carotid collar into New Zealand White rabbits decreased collar-induced endot
70 eated 40 calvarial defects in 20 12-week-old New Zealand White rabbits, divided into four groups: (1)
71 s were taken from the hippocampi of 10 male, New Zealand white rabbits during classical discriminatio
72 ere topically administered to eyes of normal New Zealand White rabbits either as a single dose or thr
73 ts of simvastatin on measures of behavior in New Zealand white rabbits embolized using a suspension o
74                  Sixteen freshly enucleated, New Zealand White rabbit eyes were investigated either i
75                              Seventy albino (New Zealand white) rabbit eyes were exposed to UVB radia
76 aced into experimental saccular aneurysms in New Zealand White rabbits failed to elicit a fibrotic re
77               Atherosclerosis was induced in New Zealand White rabbits fed 1% cholesterol for approxi
78 d alternative, via sterol 27-hydroxylase) in New Zealand white rabbits fed 3 g cholesterol/per day fo
79                                              New Zealand White rabbits fed a Western diet for 4-6 wk
80 cular injection (2 microg/kg body weight) to New Zealand White rabbits fed with a 0.25% cholesterol d
81 ramagnetic nanoparticles were compared in 30 New Zealand White rabbits (four to six rabbits per group
82             Scintigraphic images obtained in New Zealand White rabbits having acute intramuscular E.
83                                    Using the New Zealand white rabbit iliac model of stenting, we exa
84    IgG polyclonal antiserum was generated in New Zealand White rabbits immunized with a 16-mer peptid
85                                              New Zealand White rabbits immunized with AS(44-331) were
86                                              New Zealand White rabbits immunosuppressed with cyclospo
87                                 Twenty-three New Zealand White rabbits implanted intrahepatically wit
88 density, 10 mA/cm(2)) was performed on three New Zealand White rabbits in vivo.
89 ribe here a comparison of inbred and outbred New Zealand White rabbits infected by aerosol with eithe
90 HTLV-I infection and further establishes the New Zealand White rabbit inoculated with the RH/K34 cell
91 ere performed on 22 human, 29 monkey, and 34 New Zealand White rabbit intact postmortem lenses in sit
92 of radiolabeled arterial LDL was measured in New Zealand White rabbits killed at several different ti
93 Ad.nNOS in atherosclerotic arteries, 10 male New Zealand White rabbits maintained on a 1% cholesterol
94 toradiographic technique, frozen sections of New Zealand white rabbit medulla were incubated with rad
95 30 mug/mL was measured for up to 26 hrs in a New Zealand white rabbit model.
96                                       Mature New Zealand white rabbits (n = 17).
97                                   Adult male New Zealand white rabbits (n = 20), weighing 1.4-4.2 kg.
98                                              New Zealand white rabbits (n = 23), weighing 2 to 3 kg.
99                                              New Zealand White rabbits (n = 27) received a 1% cholest
100                                              New Zealand White rabbits (n = 33) were given TGF-beta(2
101      Advanced aortic lesions were induced in New Zealand White rabbits (n = 40).
102 lerotic plaques were induced in the aorta of New Zealand White rabbits (n = 7) by a repeated balloon
103 ere-loaded stents were deployed in aortas of New Zealand white rabbits (n = 8).
104                                              New Zealand White rabbits (n = 85) underwent unilateral
105                                              New Zealand white rabbits (n=10) were rendered atheroscl
106                                              New Zealand White rabbits (n=48) were studied: group 1 (
107                                              New Zealand White rabbits (n=56) underwent unilateral fe
108                                              New Zealand White rabbits (n=56) were fed a 1% cholester
109                                              New Zealand White rabbits (n=60) underwent jugular-carot
110                              Cholesterol-fed New Zealand White rabbits (n=8, 1% cholesterol diet) and
111 erol diet) and NEP-I-treated cholesterol-fed New Zealand White rabbits (n=8; candoxatril, 30 mg/kg pe
112 tion of subepithelial infiltrates in the Ad5/New Zealand White rabbit ocular model.
113  (Ad5) and their ability to replicate in the New Zealand White rabbit ocular model.
114 e compared to existing experimental data for New Zealand white rabbit patellar tendons.
115                                              New Zealand White rabbits received chow or chow suppleme
116                              Forty-one adult New Zealand White rabbits received either a single IV in
117                                 Twenty-eight New Zealand White rabbits received either normal rabbit
118 lbumin nanoparticles (nPXL) was tested in 38 New Zealand White rabbits receiving bilateral iliac arte
119 mics, and morphology was investigated in the New Zealand White rabbit renal autograft model using nea
120 ree virus from the J94356(PBMC) cell line in New Zealand White rabbits results in seroconversion to t
121            Testing was performed on 22 adult New Zealand white rabbits that received the experimental
122                  This study was performed in New Zealand White rabbits that underwent balloon angiopl
123  was performed on the iliac arteries of male New Zealand White rabbits that were fed an atherogenic d
124 ed from other locations were fed on dogs and New Zealand White rabbits to assess the competency of th
125   In vivo studies were performed on mice and New Zealand White rabbits to assess the effect of GM-CSF
126  intraarticularly to the knee joints of five New Zealand white rabbits to determine the in vivo diffu
127       Transcorneal freezing was performed in New Zealand White rabbits to induce an injury-mediated i
128 s and lactate concentration were measured in New Zealand White rabbits treated with the topical CA in
129               Surgical preparation on twelve New Zealand white rabbits under ketamine-propofol anesth
130 scribe the early response (< or =days) in 52 New Zealand White rabbits undergoing gene transfer (beta
131                                 Twenty-eight New Zealand White rabbits underwent aortic balloon injur
132                                  Thirty-nine New Zealand White rabbits underwent cryoinjury of the le
133 a after varying forms of arterial injury, 57 New Zealand White rabbits underwent iliac artery balloon
134                                              New Zealand white rabbits underwent laparotomy and expos
135                                     Pregnant New Zealand White rabbits underwent laparotomy and were
136 ized, prospective, masked-observer study, 21 New Zealand White rabbits underwent modified GFS.
137 ized, prospective, masked-observer study, 40 New Zealand White rabbits underwent modified glaucoma fi
138                                              New Zealand White rabbits underwent simultaneous balloon
139                                       Twenty New Zealand white rabbits underwent stenting of the nond
140                                              New Zealand White rabbits underwent transaortic catheter
141 hted imaging were performed on 79% gestation New Zealand white rabbits using a 3-Tesla magnetic reson
142            Periodontitis was initiated in 18 New Zealand White rabbits using ligatures around mandibu
143 Experimental periodontitis was induced in 21 New Zealand White rabbits using Porphyromonas gingivalis
144 n this animal care committee-approved study, New Zealand white rabbit VX2 liver tumors were treated t
145                One randomly chosen eye of 40 New Zealand White rabbits was assigned to silicone hydro
146                 During pregnancy, 1 group of New Zealand White rabbits was fed control chow and 8 gro
147                               One eye of six New Zealand white rabbits was given a subconjunctival in
148            PTCA of both iliac arteries of 23 New Zealand White rabbits was performed.
149  ligation of distal external iliac artery in New Zealand White rabbits, we directly injected 500 micr
150            Using the "in vivo bioreactor" in New Zealand White rabbits, we have engineered bone that
151                                              New Zealand White rabbits weighing 1.5-2.5 kg.
152                                 Corneas from New Zealand white rabbits (weight range, 2 to 3 kg) and
153                                 Fifteen male New Zealand White rabbits (weight, approximately 3.5 kg)
154                                              New Zealand White rabbits were actively immunized with F
155                                       Mature New Zealand White rabbits were anesthetized and instrume
156                                              New Zealand White rabbits were anesthetized with ketamin
157                Sixteen healthy 8-wk-old male New Zealand White rabbits were assigned to 1 of 2 groups
158                    Twenty-five pairs of male New Zealand White rabbits were challenged intraperitonea
159                                              New Zealand White rabbits were challenged with the wild-
160                                   Thirty-six New Zealand white rabbits were classified into two group
161      Male and female Sprague-Dawley rats and New Zealand White rabbits were divided into equal groups
162                        The renal pelves of 6 New Zealand White rabbits were drained by use of bilater
163                                  Hearts from New Zealand white rabbits were either chemically fixed b
164                                         Male New Zealand White rabbits were fed a 0.5% cholesterol di
165                                              New Zealand White rabbits were fed either a normal diet,
166 dysregulation of DDAH also occurred in vivo, New Zealand White rabbits were fed normal chow or a high
167 enous NO in the regulation of MCP-1 in vivo, New Zealand White rabbits were fed normal chow, normal c
168                                              New Zealand White rabbits were fed regular chow (Group A
169                                  Twenty male New Zealand white rabbits were fed regular chow with and
170                                        Forty New Zealand White rabbits were fed with cholesterol.
171                                     In vivo, New Zealand white rabbits were fit with P. aeruginosa la
172                                 Twenty-three New Zealand White rabbits were fitted unilaterally with
173                                              New Zealand White rabbits were given a periocular inject
174                                       Thirty New Zealand White rabbits were given three separate intr
175                               Eight-week-old New Zealand White rabbits were injected intravenously wi
176                                              New Zealand White rabbits were injected intravitreously
177 Anesthetized, tracheotomized, and ventilated New Zealand White rabbits were injected with freshly pre
178                                              New Zealand White rabbits were inoculated intranasally a
179                                  Twenty-four New Zealand White rabbits were instrumented with cardiac
180                                              New Zealand White rabbits were intrastromally injected w
181                                              New Zealand White rabbits were intrastromally injected w
182                                              New Zealand White rabbits were killed, and the bulbar co
183                                  Thirty male New Zealand White rabbits were maintained on a 1% choles
184                         Age- and sex-matched New Zealand White rabbits were maintained on a diet cons
185                       The IOPs of 11 healthy New Zealand White rabbits were measured with a fluid-fil
186 an globes or eyes obtained from euthanatized New Zealand White rabbits were mounted in a perfusion ch
187             Groups of sexually mature female New Zealand White rabbits were ovariectomized and killed
188                                              New Zealand white rabbits were passively immunized with
189                             Dutch-belted and New Zealand White rabbits were passively immunized with
190                                              New Zealand white rabbits were randomized to everolimus
191                                         Male New Zealand White rabbits were randomized to receive a n
192                                              New Zealand White rabbits were randomized to receive eit
193                                        Fifty New Zealand white rabbits were randomly assigned to one
194 e corneal epithelia in one eye of 8-week-old New Zealand White rabbits were scraped at weekly interva
195                                  Twenty-four New Zealand white rabbits were split into 4 groups.
196             Femoral arteries of 7 adult male New Zealand White rabbits were stenosed bilaterally to a
197                                       Twenty New Zealand White rabbits were studied before and after
198                                      Healthy New Zealand White rabbits were studied with (18)F-LMI119
199 ing sutural mineralization fronts in 8 young New Zealand White rabbits were subjected to nano-indenta
200          Near-term, 29 d gestation, pregnant New Zealand White rabbits were subjected to repetitive u
201 rtery from adult male and nonpregnant female New Zealand White rabbits were suspended in organ baths
202                                     Ten male New Zealand White rabbits were transplanted with cardiac
203                                              New Zealand White rabbits were treated topically in one
204               Isolated hearts harvested from New Zealand White rabbits were treated with either cardi
205                                              New Zealand White rabbits were used as cell donors and W
206 s (HSFs) were used for in vitro studies, and New Zealand White rabbits were used for in vivo studies.
207  CSG) were deployed in the iliac arteries of New Zealand White rabbits, which were killed 28 days aft
208                  We injected the footpads of New Zealand White rabbits with 1.7 or 8.4 nmol of tilman
209 yclonal antibodies were raised by immunizing New Zealand White rabbits with a mixture of the gel frag
210    Experimental periodontitis was induced in New Zealand white rabbits with silk sutures tied around
211                                        In 15 New Zealand White rabbits with systemic hypoxemia, AO wa
212                 Oral immunization of outbred New Zealand White rabbits with the recombinant Salmonell

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top